Literature DB >> 8406564

Complement C3 gene expression and regulation in human glomerular epithelial cells.

S H Sacks1, W Zhou, A Pani, R D Campbell, J Martin.   

Abstract

Extra-hepatic synthesis of complement is thought to mediate local tissue inflammatory injury. To investigate this phenomenon in the glomerular epithelial cell (GEC), we examined the biosynthesis and regulation of gene expression of the third component of complement in isolated human GEC derived from normal tissue. Metabolic labelling and immunoprecipitation studies demonstrated that C3 protein was synthesized, processed and secreted by GEC under basal conditions. The secreted C3 alpha and beta polypeptide chains had identical electrophoretic mobilities with those of hepatic C3. Examination of cellular RNA using semi-quantitative polymerase chain reaction (PCR) showed that C3 gene expression was present in unstimulated GEC and was increased by stimulation with interferon-gamma (IFN-gamma) in a time- and dose-dependent manner. Tumour necrosis factor-alpha (TNF-alpha), while mediating an increase in monocyte U937 C3 expression, revealed no evidence of regulation of GEC C3 gene expression. These results indicate that human GEC spontaneously express the C3 gene and that increased gene expression is regulated by IFN-gamma. These observations may reflect part of a wider mechanism of protection against or mediation of local, immune-mediated tissue injury.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406564      PMCID: PMC1421987     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  35 in total

1.  Factors leading to variation in concentration of nephrotoxic antigen(s) of glomerular basement membrane.

Authors:  C A KRAKOWER; S A GREENSPON
Journal:  AMA Arch Pathol       Date:  1954-11

Review 2.  Regulation of complement biosynthesis by tissue-specific and hormonal factors.

Authors:  A Falus
Journal:  Immunol Lett       Date:  1990-07       Impact factor: 3.685

3.  Quantitative estimation of minor mRNAs by cDNA-polymerase chain reaction. Application to dystrophin mRNA in cultured myogenic and brain cells.

Authors:  J Chelly; D Montarras; C Pinset; Y Berwald-Netter; J C Kaplan; A Kahn
Journal:  Eur J Biochem       Date:  1990-02-14

4.  Counterregulatory effects of interferon-gamma and endotoxin on expression of the human C4 genes.

Authors:  J Kulics; H R Colten; D H Perlmutter
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

5.  Modulation of collagen synthesis in human glomerular epithelial cells by interleukin 1.

Authors:  I Torbohm; B Berger; M Schönermark; J von Kempis; K Rother; G M Hänsch
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

Review 6.  The role of complement and its receptor in the elimination of immune complexes.

Authors:  J A Schifferli; Y C Ng; D K Peters
Journal:  N Engl J Med       Date:  1986-08-21       Impact factor: 91.245

Review 7.  Synthesis and secretion of complement proteins by macrophages.

Authors:  H R Colten; Y M Ooi; P J Edelson
Journal:  Ann N Y Acad Sci       Date:  1979       Impact factor: 5.691

8.  Synovial fibroblast-like cells synthesize seven proteins of the complement system.

Authors:  Y Katz; R C Strunk
Journal:  Arthritis Rheum       Date:  1988-11

9.  The complement-inhibiting protein, protectin (CD59 antigen), is present and functionally active on glomerular epithelial cells.

Authors:  I A Rooney; A Davies; D Griffiths; J D Williams; M Davies; S Meri; P J Lachmann; B P Morgan
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

10.  Human C'3: evidence for the liver as the primary site of synthesis.

Authors:  C A Alper; A M Johnson; A G Birtch; F D Moore
Journal:  Science       Date:  1969-01-17       Impact factor: 47.728

View more
  32 in total

1.  In situ localization of C3 synthesis in experimental acute renal allograft rejection.

Authors:  J R Pratt; K Abe; M Miyazaki; W Zhou; S H Sacks
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

Review 2.  The effect of locally synthesised complement on acute renal allograft rejection.

Authors:  Steven Sacks; Wuding Zhou
Journal:  J Mol Med (Berl)       Date:  2003-06-25       Impact factor: 4.599

Review 3.  Complement activation in progressive renal disease.

Authors:  Amy Fearn; Neil Stephen Sheerin
Journal:  World J Nephrol       Date:  2015-02-06

4.  Renal C3 complement component: feed forward to diabetic kidney disease.

Authors:  Katherine J Kelly; Yunlong Liu; Jizhong Zhang; Jesus H Dominguez
Journal:  Am J Nephrol       Date:  2015-01-30       Impact factor: 3.754

Review 5.  What has the immune system got against the glomerular podocyte?

Authors:  P W Mathieson
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

6.  Altered distribution of intraglomerular immune complexes in C3-deficient mice.

Authors:  N S Sheerin; T Springall; M Carroll; S H Sacks
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

7.  Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice.

Authors:  M C Pickering; J Warren; K L Rose; F Carlucci; Y Wang; M J Walport; H T Cook; M Botto
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-12       Impact factor: 11.205

Review 8.  Minimal change nephropathy and focal segmental glomerulosclerosis.

Authors:  Peter W Mathieson
Journal:  Semin Immunopathol       Date:  2007-10-23       Impact factor: 9.623

9.  Regulation of C3 and factor H synthesis of human glomerular mesangial cells by IL-1 and interferon-gamma.

Authors:  M E van den Dobbelsteen; V Verhasselt; J G Kaashoek; J J Timmerman; W E Schroeijers; C L Verweij; F J van der Woude; L A van Es; M R Daha
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

10.  Interferon-gamma (IFN-gamma) and IL-4 expressed during mercury-induced membranous nephropathy are toxic for cultured podocytes.

Authors:  W Coers; J T Vos; P H Van der Meide; M L Van der Horst; S Huitema; J J Weening
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.